04/24/2025
3:15 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
3:20 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025
3:25 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/01/2025
4:35 PM | Madison Avenue Partners, LP (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/26/2025
3:36 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
9:01 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/04/2025
3:45 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:16 PM | Sage Therapeutics (Filer)
| Form POS AM | |
02/05/2025
9:41 AM | MORGAN STANLEY (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for SAGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/31/2025
8:55 AM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
8:28 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
5:02 AM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
5:06 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:34 PM | BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13D | |
12/27/2024
3:11 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:47 PM | JONAS JEFFREY M (Reporting)
Sage Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:42 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:40 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:14 PM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:56 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
2:28 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:23 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2024
3:24 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:20 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
10:37 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
6:11 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
5:37 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
6:07 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:33 AM | Sage Therapeutics (Filer)
| Form S-3ASR | |
07/31/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:15 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
5:39 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy SAGE Stock Free SAGE Stock Alerts